Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Zentalis Pharmaceuticals, Llc (ZNTL)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 84,924,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. Co. is developing a pipeline of product candidates with an initial focus on validated oncology targets. Co. has two primary product candidates: ZN-c3, an inhibitor of Wee1, a protein tyrosine kinase, and ZN-c5, an oral selective estrogen receptor degrader. Co.'s other clinical product candidates include ZN-d5, a selective inhibitor of B-cell lymphoma 2 and ZN-e4, an irreversible inhibitor of mutant epidermal growth factor receptor.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 22,000 22,000
Total Buy Value $0 $0 $219,391 $219,391
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 2 2
Total Shares Sold 3,356 32,218 167,164 362,029
Total Sell Value $42,353 $375,045 $4,063,616 $8,774,551
Total People Sold 1 5 8 8
Total Sell Transactions 1 7 13 35
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 237
  Page 5 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Voliotis Dimitris SVP, Clinical Development   •       –      –    2022-01-19 4 OE $18.00 $180,000 D/D 10,000 16,250     -
   Voliotis Dimitris SVP, Clinical Development   •       –      –    2022-01-18 4 AS $61.70 $626,491 D/D (10,000) 6,250     -
   Voliotis Dimitris SVP, Clinical Development   •       –      –    2022-01-18 4 OE $18.00 $180,000 D/D 10,000 16,250     -
   Gallagher Cam Director   –       •      –    2022-01-18 4 AS $61.71 $626,376 D/D (10,000) 397,203     -
   Bunker Kevin D. Chief Operating Officer   •       –      –    2022-01-10 4 AS $67.24 $684,097 I/I (10,000) 190,000     -
   Gallagher Cam Director   –       •      –    2022-01-05 4 AS $73.18 $754,861 D/D (10,000) 407,203     -
   Sun Anthony Y President & CEO   •       •      –    2022-01-04 4 AS $77.71 $823,870 D/D (10,471) 1,192,717     -
   Blackwell Kimberly Director   –       •      –    2022-01-03 4 AS $83.74 $83,740 D/D (1,000) 5,000     -
   Blackwell Kimberly Director   –       •      –    2022-01-03 4 OE $47.80 $47,800 D/D 1,000 6,000     -
   Sun Anthony Y President & CEO   •       •      –    2022-01-03 4 AS $78.26 $838,438 D/D (10,471) 1,203,188     -
   Bunker Kevin D. Chief Operating Officer   •       –      –    2021-12-30 4 GD $0.00 $0 D/D 8,750 746,317     -
   Bunker Kevin D. Chief Operating Officer   •       –      –    2021-12-20 4 AS $77.45 $792,431 I/I (10,000) 200,000     -
   Sun Anthony Y President & CEO   •       •      –    2021-12-16 4 GD $0.00 $0 D/D 15,000 1,213,659     -
   Gallagher Cam Director   –       •      –    2021-12-15 4 AS $71.28 $740,337 D/D (10,000) 417,203     -
   Bunker Kevin D. Chief Operating Officer   •       –      –    2021-12-10 4 AS $70.29 $717,106 I/I (10,000) 210,000     -
   Gallagher Cam Director   –       •      –    2021-12-06 4 AS $71.33 $713,300 D/D (10,000) 427,203     -
   Sun Anthony Y President & CEO   •       •      –    2021-11-26 4/A GD $0.00 $0 I/I 125,000 103,650     -
   Gallagher Cam Director   –       •      –    2021-11-15 4 AS $75.02 $753,619 D/D (10,000) 437,203     -
   Bunker Kevin D. Chief Operating Officer   •       –      –    2021-11-10 4 AS $78.15 $781,471 I/I (10,000) 230,000     -
   Bunker Kevin D. Chief Operating Officer   •       –      –    2021-11-09 4 GA $0.00 $0 I/I 240,000 240,000     -
   Bunker Kevin D. Chief Operating Officer   •       –      –    2021-11-09 4 GD $0.00 $0 D/D 240,000 755,067     -
   Gallagher Cam Director   –       •      –    2021-11-05 4 AS $82.09 $829,491 D/D (10,000) 447,203     -
   Sun Anthony Y President & CEO   •       •      –    2021-11-02 4 AS $79.40 $842,602 D/D (10,471) 1,249,601     -
   Sun Anthony Y President & CEO   •       •      –    2021-11-01 4 AS $80.72 $852,772 D/D (10,471) 1,260,072     -
   Blackwell Kimberly Director   –       •      –    2021-11-01 4 AS $80.46 $80,460 D/D (1,000) 5,000     -

  237 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed